Global Virus Like Particles Market Growth 2025-2031

October 2025 | 116 pages | ID: G813920DF757EN
LP Information

Abstracts

The global Virus Like Particles market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Virus Like Particles is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Virus Like Particles is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Virus Like Particles is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Virus Like Particles players cover GlaxoSmithKline, Merck, Novavax, Takeda, Medicago, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Virus Like Particles Industry Forecast” looks at past sales and reviews total world Virus Like Particles sales in 2024, providing a comprehensive analysis by region and market sector of projected Virus Like Particles sales for 2025 through 2031. With Virus Like Particles sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Virus Like Particles industry.

This Insight Report provides a comprehensive analysis of the global Virus Like Particles landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Virus Like Particles portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Virus Like Particles market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Virus Like Particles and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Virus Like Particles.

This report presents a comprehensive overview, market shares, and growth opportunities of Virus Like Particles market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Adeno-Associated Virus
• HIV
• Hepatitis B Virus
• Hepatitis C Virus
• Others

Segmentation by Application:

• Vaccines
• Mycoviruses
• Virus Research
• Therapeutic and Imaging Agents
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• GlaxoSmithKline
• Merck
• Novavax
• Takeda
• Medicago
• MedImmune
• TechnoVax
• Agilvax
• Allergy Therapeutics
• Serum Institute of India
• GeoVax Labs
• Cytos Biotechnology
• ANGANY Genetics
• CPL Biologicals
• Xiamen Innovax Biotech

Key Questions Addressed in this Report

What is the 10-year outlook for the global Virus Like Particles market?
What factors are driving Virus Like Particles market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Virus Like Particles market opportunities vary by end market size?
How does Virus Like Particles break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Baby Wipes Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Baby Wipes by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Baby Wipes by Country/Region, 2020, 2024 & 2031
2.2 Baby Wipes Segment by Type
  2.2.1 Spunlace
  2.2.2 Airlaid
  2.2.3 Coform
  2.2.4 Needle Punch
2.3 Baby Wipes Sales by Type
  2.3.1 Global Baby Wipes Sales Market Share by Type (2020-2025)
  2.3.2 Global Baby Wipes Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Baby Wipes Sale Price by Type (2020-2025)
2.4 Baby Wipes Segment by Application
  2.4.1 Retail Sales
  2.4.2 Departmental Stores
  2.4.3 Medical Stores
  2.4.4 Brand Outlets
2.5 Baby Wipes Sales by Application
  2.5.1 Global Baby Wipes Sale Market Share by Application (2020-2025)
  2.5.2 Global Baby Wipes Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Baby Wipes Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Baby Wipes Breakdown Data by Company
  3.1.1 Global Baby Wipes Annual Sales by Company (2020-2025)
  3.1.2 Global Baby Wipes Sales Market Share by Company (2020-2025)
3.2 Global Baby Wipes Annual Revenue by Company (2020-2025)
  3.2.1 Global Baby Wipes Revenue by Company (2020-2025)
  3.2.2 Global Baby Wipes Revenue Market Share by Company (2020-2025)
3.3 Global Baby Wipes Sale Price by Company
3.4 Key Manufacturers Baby Wipes Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Baby Wipes Product Location Distribution
  3.4.2 Players Baby Wipes Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR BABY WIPES BY GEOGRAPHIC REGION

4.1 World Historic Baby Wipes Market Size by Geographic Region (2020-2025)
  4.1.1 Global Baby Wipes Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Baby Wipes Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Baby Wipes Market Size by Country/Region (2020-2025)
  4.2.1 Global Baby Wipes Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Baby Wipes Annual Revenue by Country/Region (2020-2025)
4.3 Americas Baby Wipes Sales Growth
4.4 APAC Baby Wipes Sales Growth
4.5 Europe Baby Wipes Sales Growth
4.6 Middle East & Africa Baby Wipes Sales Growth

5 AMERICAS

5.1 Americas Baby Wipes Sales by Country
  5.1.1 Americas Baby Wipes Sales by Country (2020-2025)
  5.1.2 Americas Baby Wipes Revenue by Country (2020-2025)
5.2 Americas Baby Wipes Sales by Type (2020-2025)
5.3 Americas Baby Wipes Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Baby Wipes Sales by Region
  6.1.1 APAC Baby Wipes Sales by Region (2020-2025)
  6.1.2 APAC Baby Wipes Revenue by Region (2020-2025)
6.2 APAC Baby Wipes Sales by Type (2020-2025)
6.3 APAC Baby Wipes Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Baby Wipes by Country
  7.1.1 Europe Baby Wipes Sales by Country (2020-2025)
  7.1.2 Europe Baby Wipes Revenue by Country (2020-2025)
7.2 Europe Baby Wipes Sales by Type (2020-2025)
7.3 Europe Baby Wipes Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Baby Wipes by Country
  8.1.1 Middle East & Africa Baby Wipes Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Baby Wipes Revenue by Country (2020-2025)
8.2 Middle East & Africa Baby Wipes Sales by Type (2020-2025)
8.3 Middle East & Africa Baby Wipes Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Baby Wipes
10.3 Manufacturing Process Analysis of Baby Wipes
10.4 Industry Chain Structure of Baby Wipes

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Baby Wipes Distributors
11.3 Baby Wipes Customer

12 WORLD FORECAST REVIEW FOR BABY WIPES BY GEOGRAPHIC REGION

12.1 Global Baby Wipes Market Size Forecast by Region
  12.1.1 Global Baby Wipes Forecast by Region (2026-2031)
  12.1.2 Global Baby Wipes Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Baby Wipes Forecast by Type (2026-2031)
12.7 Global Baby Wipes Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Kimberly-Clark
  13.1.1 Kimberly-Clark Company Information
  13.1.2 Kimberly-Clark Baby Wipes Product Portfolios and Specifications
  13.1.3 Kimberly-Clark Baby Wipes Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Kimberly-Clark Main Business Overview
  13.1.5 Kimberly-Clark Latest Developments
13.2 Johnson & Johnson
  13.2.1 Johnson & Johnson Company Information
  13.2.2 Johnson & Johnson Baby Wipes Product Portfolios and Specifications
  13.2.3 Johnson & Johnson Baby Wipes Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Johnson & Johnson Main Business Overview
  13.2.5 Johnson & Johnson Latest Developments
13.3 P&G
  13.3.1 P&G Company Information
  13.3.2 P&G Baby Wipes Product Portfolios and Specifications
  13.3.3 P&G Baby Wipes Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 P&G Main Business Overview
  13.3.5 P&G Latest Developments
13.4 Unicharm
  13.4.1 Unicharm Company Information
  13.4.2 Unicharm Baby Wipes Product Portfolios and Specifications
  13.4.3 Unicharm Baby Wipes Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Unicharm Main Business Overview
  13.4.5 Unicharm Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Virus Like Particles Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Virus Like Particles Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Adeno-Associated Virus
Table 4. Major Players of HIV
Table 5. Major Players of Hepatitis B Virus
Table 6. Major Players of Hepatitis C Virus
Table 7. Major Players of Others
Table 8. Global Virus Like Particles Sales by Type (2020-2025) & (K Dose)
Table 9. Global Virus Like Particles Sales Market Share by Type (2020-2025)
Table 10. Global Virus Like Particles Revenue by Type (2020-2025) & ($ million)
Table 11. Global Virus Like Particles Revenue Market Share by Type (2020-2025)
Table 12. Global Virus Like Particles Sale Price by Type (2020-2025) & (USD/Dose)
Table 13. Global Virus Like Particles Sale by Application (2020-2025) & (K Dose)
Table 14. Global Virus Like Particles Sale Market Share by Application (2020-2025)
Table 15. Global Virus Like Particles Revenue by Application (2020-2025) & ($ million)
Table 16. Global Virus Like Particles Revenue Market Share by Application (2020-2025)
Table 17. Global Virus Like Particles Sale Price by Application (2020-2025) & (USD/Dose)
Table 18. Global Virus Like Particles Sales by Company (2020-2025) & (K Dose)
Table 19. Global Virus Like Particles Sales Market Share by Company (2020-2025)
Table 20. Global Virus Like Particles Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Virus Like Particles Revenue Market Share by Company (2020-2025)
Table 22. Global Virus Like Particles Sale Price by Company (2020-2025) & (USD/Dose)
Table 23. Key Manufacturers Virus Like Particles Producing Area Distribution and Sales Area
Table 24. Players Virus Like Particles Products Offered
Table 25. Virus Like Particles Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Virus Like Particles Sales by Geographic Region (2020-2025) & (K Dose)
Table 29. Global Virus Like Particles Sales Market Share Geographic Region (2020-2025)
Table 30. Global Virus Like Particles Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Virus Like Particles Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Virus Like Particles Sales by Country/Region (2020-2025) & (K Dose)
Table 33. Global Virus Like Particles Sales Market Share by Country/Region (2020-2025)
Table 34. Global Virus Like Particles Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Virus Like Particles Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Virus Like Particles Sales by Country (2020-2025) & (K Dose)
Table 37. Americas Virus Like Particles Sales Market Share by Country (2020-2025)
Table 38. Americas Virus Like Particles Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Virus Like Particles Sales by Type (2020-2025) & (K Dose)
Table 40. Americas Virus Like Particles Sales by Application (2020-2025) & (K Dose)
Table 41. APAC Virus Like Particles Sales by Region (2020-2025) & (K Dose)
Table 42. APAC Virus Like Particles Sales Market Share by Region (2020-2025)
Table 43. APAC Virus Like Particles Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Virus Like Particles Sales by Type (2020-2025) & (K Dose)
Table 45. APAC Virus Like Particles Sales by Application (2020-2025) & (K Dose)
Table 46. Europe Virus Like Particles Sales by Country (2020-2025) & (K Dose)
Table 47. Europe Virus Like Particles Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Virus Like Particles Sales by Type (2020-2025) & (K Dose)
Table 49. Europe Virus Like Particles Sales by Application (2020-2025) & (K Dose)
Table 50. Middle East & Africa Virus Like Particles Sales by Country (2020-2025) & (K Dose)
Table 51. Middle East & Africa Virus Like Particles Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Virus Like Particles Sales by Type (2020-2025) & (K Dose)
Table 53. Middle East & Africa Virus Like Particles Sales by Application (2020-2025) & (K Dose)
Table 54. Key Market Drivers & Growth Opportunities of Virus Like Particles
Table 55. Key Market Challenges & Risks of Virus Like Particles
Table 56. Key Industry Trends of Virus Like Particles
Table 57. Virus Like Particles Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Virus Like Particles Distributors List
Table 60. Virus Like Particles Customer List
Table 61. Global Virus Like Particles Sales Forecast by Region (2026-2031) & (K Dose)
Table 62. Global Virus Like Particles Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Virus Like Particles Sales Forecast by Country (2026-2031) & (K Dose)
Table 64. Americas Virus Like Particles Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Virus Like Particles Sales Forecast by Region (2026-2031) & (K Dose)
Table 66. APAC Virus Like Particles Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Virus Like Particles Sales Forecast by Country (2026-2031) & (K Dose)
Table 68. Europe Virus Like Particles Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Virus Like Particles Sales Forecast by Country (2026-2031) & (K Dose)
Table 70. Middle East & Africa Virus Like Particles Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Virus Like Particles Sales Forecast by Type (2026-2031) & (K Dose)
Table 72. Global Virus Like Particles Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Virus Like Particles Sales Forecast by Application (2026-2031) & (K Dose)
Table 74. Global Virus Like Particles Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. GlaxoSmithKline Basic Information, Virus Like Particles Manufacturing Base, Sales Area and Its Competitors
Table 76. GlaxoSmithKline Virus Like Particles Product Portfolios and Specifications
Table 77. GlaxoSmithKline Virus Like Particles Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 78. GlaxoSmithKline Main Business
Table 79. GlaxoSmithKline Latest Developments
Table 80. Merck Basic Information, Virus Like Particles Manufacturing Base, Sales Area and Its Competitors
Table 81. Merck Virus Like Particles Product Portfolios and Specifications
Table 82. Merck Virus Like Particles Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 83. Merck Main Business
Table 84. Merck Latest Developments
Table 85. Novavax Basic Information, Virus Like Particles Manufacturing Base, Sales Area and Its Competitors
Table 86. Novavax Virus Like Particles Product Portfolios and Specifications
Table 87. Novavax Virus Like Particles Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 88. Novavax Main Business
Table 89. Novavax Latest Developments
Table 90. Takeda Basic Information, Virus Like Particles Manufacturing Base, Sales Area and Its Competitors
Table 91. Takeda Virus Like Particles Product Portfolios and Specifications
Table 92. Takeda Virus Like Particles Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 93. Takeda Main Business
Table 94. Takeda Latest Developments
Table 95. Medicago Basic Information, Virus Like Particles Manufacturing Base, Sales Area and Its Competitors
Table 96. Medicago Virus Like Particles Product Portfolios and Specifications
Table 97. Medicago Virus Like Particles Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 98. Medicago Main Business
Table 99. Medicago Latest Developments
Table 100. MedImmune Basic Information, Virus Like Particles Manufacturing Base, Sales Area and Its Competitors
Table 101. MedImmune Virus Like Particles Product Portfolios and Specifications
Table 102. MedImmune Virus Like Particles Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 103. MedImmune Main Business
Table 104. MedImmune Latest Developments
Table 105. TechnoVax Basic Information, Virus Like Particles Manufacturing Base, Sales Area and Its Competitors
Table 106. TechnoVax Virus Like Particles Product Portfolios and Specifications
Table 107. TechnoVax Virus Like Particles Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 108. TechnoVax Main Business
Table 109. TechnoVax Latest Developments
Table 110. Agilvax Basic Information, Virus Like Particles Manufacturing Base, Sales Area and Its Competitors
Table 111. Agilvax Virus Like Particles Product Portfolios and Specifications
Table 112. Agilvax Virus Like Particles Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 113. Agilvax Main Business
Table 114. Agilvax Latest Developments
Table 115. Allergy Therapeutics Basic Information, Virus Like Particles Manufacturing Base, Sales Area and Its Competitors
Table 116. Allergy Therapeutics Virus Like Particles Product Portfolios and Specifications
Table 117. Allergy Therapeutics Virus Like Particles Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 118. Allergy Therapeutics Main Business
Table 119. Allergy Therapeutics Latest Developments
Table 120. Serum Institute of India Basic Information, Virus Like Particles Manufacturing Base, Sales Area and Its Competitors
Table 121. Serum Institute of India Virus Like Particles Product Portfolios and Specifications
Table 122. Serum Institute of India Virus Like Particles Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 123. Serum Institute of India Main Business
Table 124. Serum Institute of India Latest Developments
Table 125. GeoVax Labs Basic Information, Virus Like Particles Manufacturing Base, Sales Area and Its Competitors
Table 126. GeoVax Labs Virus Like Particles Product Portfolios and Specifications
Table 127. GeoVax Labs Virus Like Particles Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 128. GeoVax Labs Main Business
Table 129. GeoVax Labs Latest Developments
Table 130. Cytos Biotechnology Basic Information, Virus Like Particles Manufacturing Base, Sales Area and Its Competitors
Table 131. Cytos Biotechnology Virus Like Particles Product Portfolios and Specifications
Table 132. Cytos Biotechnology Virus Like Particles Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 133. Cytos Biotechnology Main Business
Table 134. Cytos Biotechnology Latest Developments
Table 135. ANGANY Genetics Basic Information, Virus Like Particles Manufacturing Base, Sales Area and Its Competitors
Table 136. ANGANY Genetics Virus Like Particles Product Portfolios and Specifications
Table 137. ANGANY Genetics Virus Like Particles Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 138. ANGANY Genetics Main Business
Table 139. ANGANY Genetics Latest Developments
Table 140. CPL Biologicals Basic Information, Virus Like Particles Manufacturing Base, Sales Area and Its Competitors
Table 141. CPL Biologicals Virus Like Particles Product Portfolios and Specifications
Table 142. CPL Biologicals Virus Like Particles Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 143. CPL Biologicals Main Business
Table 144. CPL Biologicals Latest Developments
Table 145. Xiamen Innovax Biotech Basic Information, Virus Like Particles Manufacturing Base, Sales Area and Its Competitors
Table 146. Xiamen Innovax Biotech Virus Like Particles Product Portfolios and Specifications
Table 147. Xiamen Innovax Biotech Virus Like Particles Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 148. Xiamen Innovax Biotech Main Business
Table 149. Xiamen Innovax Biotech Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Virus Like Particles
Figure 2. Virus Like Particles Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Virus Like Particles Sales Growth Rate 2020-2031 (K Dose)
Figure 7. Global Virus Like Particles Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Virus Like Particles Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Virus Like Particles Sales Market Share by Country/Region (2024)
Figure 10. Virus Like Particles Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Adeno-Associated Virus
Figure 12. Product Picture of HIV
Figure 13. Product Picture of Hepatitis B Virus
Figure 14. Product Picture of Hepatitis C Virus
Figure 15. Product Picture of Others
Figure 16. Global Virus Like Particles Sales Market Share by Type in 2025
Figure 17. Global Virus Like Particles Revenue Market Share by Type (2020-2025)
Figure 18. Virus Like Particles Consumed in Vaccines
Figure 19. Global Virus Like Particles Market: Vaccines (2020-2025) & (K Dose)
Figure 20. Virus Like Particles Consumed in Mycoviruses
Figure 21. Global Virus Like Particles Market: Mycoviruses (2020-2025) & (K Dose)
Figure 22. Virus Like Particles Consumed in Virus Research
Figure 23. Global Virus Like Particles Market: Virus Research (2020-2025) & (K Dose)
Figure 24. Virus Like Particles Consumed in Therapeutic and Imaging Agents
Figure 25. Global Virus Like Particles Market: Therapeutic and Imaging Agents (2020-2025) & (K Dose)
Figure 26. Virus Like Particles Consumed in Others
Figure 27. Global Virus Like Particles Market: Others (2020-2025) & (K Dose)
Figure 28. Global Virus Like Particles Sale Market Share by Application (2024)
Figure 29. Global Virus Like Particles Revenue Market Share by Application in 2025
Figure 30. Virus Like Particles Sales by Company in 2025 (K Dose)
Figure 31. Global Virus Like Particles Sales Market Share by Company in 2025
Figure 32. Virus Like Particles Revenue by Company in 2025 ($ millions)
Figure 33. Global Virus Like Particles Revenue Market Share by Company in 2025
Figure 34. Global Virus Like Particles Sales Market Share by Geographic Region (2020-2025)
Figure 35. Global Virus Like Particles Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Virus Like Particles Sales 2020-2025 (K Dose)
Figure 37. Americas Virus Like Particles Revenue 2020-2025 ($ millions)
Figure 38. APAC Virus Like Particles Sales 2020-2025 (K Dose)
Figure 39. APAC Virus Like Particles Revenue 2020-2025 ($ millions)
Figure 40. Europe Virus Like Particles Sales 2020-2025 (K Dose)
Figure 41. Europe Virus Like Particles Revenue 2020-2025 ($ millions)
Figure 42. Middle East & Africa Virus Like Particles Sales 2020-2025 (K Dose)
Figure 43. Middle East & Africa Virus Like Particles Revenue 2020-2025 ($ millions)
Figure 44. Americas Virus Like Particles Sales Market Share by Country in 2025
Figure 45. Americas Virus Like Particles Revenue Market Share by Country (2020-2025)
Figure 46. Americas Virus Like Particles Sales Market Share by Type (2020-2025)
Figure 47. Americas Virus Like Particles Sales Market Share by Application (2020-2025)
Figure 48. United States Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 49. Canada Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 50. Mexico Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 51. Brazil Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 52. APAC Virus Like Particles Sales Market Share by Region in 2025
Figure 53. APAC Virus Like Particles Revenue Market Share by Region (2020-2025)
Figure 54. APAC Virus Like Particles Sales Market Share by Type (2020-2025)
Figure 55. APAC Virus Like Particles Sales Market Share by Application (2020-2025)
Figure 56. China Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 57. Japan Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 58. South Korea Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 59. Southeast Asia Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 60. India Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 61. Australia Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 62. China Taiwan Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 63. Europe Virus Like Particles Sales Market Share by Country in 2025
Figure 64. Europe Virus Like Particles Revenue Market Share by Country (2020-2025)
Figure 65. Europe Virus Like Particles Sales Market Share by Type (2020-2025)
Figure 66. Europe Virus Like Particles Sales Market Share by Application (2020-2025)
Figure 67. Germany Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 68. France Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 69. UK Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 70. Italy Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 71. Russia Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 72. Middle East & Africa Virus Like Particles Sales Market Share by Country (2020-2025)
Figure 73. Middle East & Africa Virus Like Particles Sales Market Share by Type (2020-2025)
Figure 74. Middle East & Africa Virus Like Particles Sales Market Share by Application (2020-2025)
Figure 75. Egypt Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 76. South Africa Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 77. Israel Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 78. Turkey Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 79. GCC Countries Virus Like Particles Revenue Growth 2020-2025 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Virus Like Particles in 2025
Figure 81. Manufacturing Process Analysis of Virus Like Particles
Figure 82. Industry Chain Structure of Virus Like Particles
Figure 83. Channels of Distribution
Figure 84. Global Virus Like Particles Sales Market Forecast by Region (2026-2031)
Figure 85. Global Virus Like Particles Revenue Market Share Forecast by Region (2026-2031)
Figure 86. Global Virus Like Particles Sales Market Share Forecast by Type (2026-2031)
Figure 87. Global Virus Like Particles Revenue Market Share Forecast by Type (2026-2031)
Figure 88. Global Virus Like Particles Sales Market Share Forecast by Application (2026-2031)
Figure 89. Global Virus Like Particles Revenue Market Share Forecast by Application (2026-2031)